Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 12/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 4/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | MST1 | P26927 | 1/20 | 0.33 |
| ▸ | STK4 | Q13043 | 1/20 | 0.33 |
| ▸ | STK3 | Q13188 | 1/20 | 0.33 |
| ▸ | STK26 | Q9P289 | 1/20 | 0.33 |
| ▸ | FLT1 | P17948 | 1/20 | 0.33 |
| ▸ | FLT4 | P35916 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21929248 | 0.91 | TNKS (0.37) | PTGER4 | |
| SCHEMBL21928998 | 0.89 | GRM5 (0.35) | LRRK2CLK4GRM5PGRFLT1 | |
| SCHEMBL21738621 | 0.87 | CYP1A2 (0.30) | PTGER4 | |
| SCHEMBL21928569 | 0.87 | CLK4 (0.35) | LRRK2CLK4GRM5 | |
| SCHEMBL21546473 | 0.85 | PGR (0.38) | LRRK2CLK4PGRMST1STK4 | |
| SCHEMBL21931810 | 0.84 | IMPDH2 (0.31) | LRRK2 | |
| SCHEMBL21928382 | 0.84 | CYP1A2 (0.38) | CLK4GRM5PTGER4 | |
| SCHEMBL21928378 | 0.83 | GABRP (0.35) | LRRK2GRM5PTGER4 | |
| SCHEMBL20769875 | 0.83 | GRM5 (0.41) | LRRK2CLK4GRM5PTGER4 | |
| SCHEMBL21928592 | 0.83 | PGR (0.35) | LRRK2CLK4PGRFLT1FLT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | CYNORA GMBH (DE) | 2022-12-08 | — | — | US | disclosed |
| EP-3609978-B1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | ALDH1A2, AOX1, CYBA | LRRK2 1976/4885CLK4 4420/4885GRM5 2961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.